AU7669496A - Method for the intranasal administration of l-dopa prodrugs - Google Patents

Method for the intranasal administration of l-dopa prodrugs

Info

Publication number
AU7669496A
AU7669496A AU76694/96A AU7669496A AU7669496A AU 7669496 A AU7669496 A AU 7669496A AU 76694/96 A AU76694/96 A AU 76694/96A AU 7669496 A AU7669496 A AU 7669496A AU 7669496 A AU7669496 A AU 7669496A
Authority
AU
Australia
Prior art keywords
intranasal administration
dopa prodrugs
dopa
prodrugs
intranasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76694/96A
Inventor
Lewis Dittert
Anwar A. Hussain
Soichi Itoh
Huaihung Danny Kao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky
Original Assignee
University of Kentucky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky filed Critical University of Kentucky
Publication of AU7669496A publication Critical patent/AU7669496A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU76694/96A 1995-11-03 1996-11-04 Method for the intranasal administration of l-dopa prodrugs Abandoned AU7669496A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55277795A 1995-11-03 1995-11-03
US552777 1995-11-03
PCT/US1996/017740 WO1997016181A1 (en) 1995-11-03 1996-11-04 Method for the intranasal administration of l-dopa prodrugs

Publications (1)

Publication Number Publication Date
AU7669496A true AU7669496A (en) 1997-05-22

Family

ID=24206768

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76694/96A Abandoned AU7669496A (en) 1995-11-03 1996-11-04 Method for the intranasal administration of l-dopa prodrugs

Country Status (2)

Country Link
AU (1) AU7669496A (en)
WO (1) WO1997016181A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS4516A (en) 1997-07-01 1999-01-02 Gizurarson Sveinbjörn New pharmaceutical form
EP1392262A1 (en) 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
ES2594867T3 (en) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
AU2009236078B2 (en) 2008-04-18 2014-03-06 Arizona Board Of Regents, A Body Corp. Of The State Of Arizona, Acting For And On Behalf Of The University Of Arizona Methods and compositions for treating age-related macular degeneration
CA3000016A1 (en) 2015-11-06 2017-05-11 Gemphire Therapeutics Inc. Gemcabene combinations for the treatment of cardiovascular disease
AU2019348194A1 (en) * 2018-09-28 2021-04-29 Griffith University Agents and methods for modulating pathogen activity
WO2020160256A1 (en) 2019-01-31 2020-08-06 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating or limiting development of age-related macular degeneration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663349A (en) * 1985-12-30 1987-05-05 Merck & Co., Inc. Rectally absorbable form of L-dopa
US5354885A (en) * 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA

Also Published As

Publication number Publication date
WO1997016181A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AUPN453895A0 (en) Spray method
AU7445396A (en) Two-piece dental abutment
AU5910796A (en) Method of producing L-lysine
AU4698396A (en) Process for modifying surfaces
AU1201797A (en) Nebulizer
AUPN449295A0 (en) Radioprotectors
AU5779196A (en) Novel 2-amino-3-phenylpropionic acid derivatives
AU5821096A (en) New catechol derivatives
AU4838996A (en) Process for tetraazacycloalkane preparation
HUP9601524A2 (en) Prodrugs of paclytaxel-derivatives
EP0747346A3 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
AU6707396A (en) Processes for the production of amidase
AU7669496A (en) Method for the intranasal administration of l-dopa prodrugs
AU4352996A (en) Connector
AU4726196A (en) Clavulanic acid salts
AU2008895A (en) Connector
AU4396396A (en) Baby-bathing aid
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU5486396A (en) Process for the preparation of spiroindolines
AU4926496A (en) Method for the production of d-chiroinositol
AU4547896A (en) 4-oxo-2-butenoic acid derivatives
EP0750373A3 (en) Connector
AU7639996A (en) Nozzle
AU1118797A (en) Process
AU7335496A (en) Hyroxamic acid derivatives